Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study
<p>Abstract</p> <p>Background</p> <p>Experimentally, erythropoietin (EPO) has nephroprotective as well as immunomodulatory properties when administered after ischemic renal injury. We tested the hypothesis that different doses of recombinant human EPO administered to patients after cardiac surgery w...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2012-10-01
|
| Serija: | BMC Nephrology |
| Teme: | |
| Online dostop: | http://www.biomedcentral.com/1471-2369/13/132 |
| Oznake: |
Brez oznak, prvi označite!
|
